Temasek Holdings’ unit Accuron MedTech has led a S$2.6 million ($1.9 million) pre-Series A round in Singapore-based startup Advent Access, which is developing a vascular access device for dialysis patients, according to an announcement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
